Tick-Killing Pill Offers Hope in Lyme Disease Battle
Tarsus Pharmaceuticals is developing a pill for humans that could provide protection against Lyme disease for several weeks at a time by killing ticks on people within 24 hours of ingestion, with effects lasting up to 30 days. With Lyme disease being a growing problem in the United States, the experimental pill, a formulation of lotilaner, aims to offer a more effective prevention method than current options such as insect repellents and permethrin-treated clothing. This development comes as a promising new weapon in the fight against tick-borne diseases, addressing the need for better prevention strategies and potential health issues associated with Lyme disease.